Gynecologic oncology is evolving beyond surgery, with greater focus on systemic therapies, team-based care and improved patient outcomes. Dr. Stephanie Blank, a gynecologic oncology leader at Mount ...

There is no expiration date written into the guidelines.

A single-center real-world study compares the effectiveness and toxicity of chimeric antigen receptor T-cell therapy vs ...

Serial metastasis-directed radiotherapy extended time off systemic therapy while maintaining favorable progression-free and overall survival in patients with oligometastatic clear-cell renal cell ...

Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an idea of how much the field has changed, clinical guidelines on psoriasis ...

Trastuzumab Deruxtecan Is Active in Desmoplastic Small Round Cell Tumor We reviewed 168 patients with soft tissue LMS who received systemic therapy between 2009 and 2024 for metastatic LMS and also ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

Advances in systemic therapies, particularly biologics, have improved outcomes for moderate-to-severe psoriasis, though access remains uneven due to insurance and cost barriers. Effective psoriasis ...

After decades of research on sleep and relationships, the evidence is overwhelming: For most adults, sleep is fundamentally a dyadic process. Yet sleep medicine continues to treat it as an individual ...

Intravitreal ceftazidime may help treat syphilitic uveitis when IV penicillin is delayed. Ceftazidime is not a substitute for IV penicillin, which is the preferred treatment. A case series reported ...